Koyfin Home > Directory > Health Care > Abeona Therapeutics > Net Debt / EBITDA

Abeona Therapeutics Net Debt / EBITDA Chart (ABEO)

Abeona Therapeutics annual/quarterly Net Debt / EBITDA from 2010 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • Abeona Therapeutics Net Debt / EBITDA for the quarter ending June 06, 2020 was $2m a 70.28% increase of 2m year over year
  • Abeona Therapeutics Net Debt / EBITDA for the last 12 months ending June 06, 2020 was $2m a 69.47% increase of 1m year over year
  • Abeona Therapeutics Annual Net Debt / EBITDA for 2019 was $2m a 15.62% increase of 0m from 2018
  • Abeona Therapeutics Annual Net Debt / EBITDA for 2018 was $2m a -233.91% decrease of -4m from 2017
  • Abeona Therapeutics Annual Net Debt / EBITDA for 2017 was $5m a 41.01% increase of 2m from 2016
Other Ratios Metrics:
  • Abeona Therapeutics Total Debt / Capital for the quarter ending December 12, 2014 was $8m a -1,061.80% decrease of -81m year over year
  • Abeona Therapeutics Other Liabilities for the quarter ending December 12, 2017 was $3m a -14.77% decrease of 0m year over year
  • Abeona Therapeutics Total Debt / Equity for the quarter ending December 12, 2014 was $8m a -36,027.59% decrease of -2,992m year over year
View Chart On Koyfin

Quarterly ABEO Net Debt / EBITDA Data

06/2020$2m
03/2020$2m
12/2019$2m
09/2019$1m
06/2019$1m
03/2019$1m
12/2018$1m
09/2018$2m
06/2018$2m
03/2018$3m

Annual ABEO Net Debt / EBITDA Data

2019$2m
2018$2m
2017$5m
2016$3m
2015$2m
2014$4m
2013$0m
2012$0m
2011$0m
2010$0m